Keywords: FDA; Food and Drug Administration; MHLW; Ministry of Health, Labour and Welfare; PMDA; Pharmaceuticals and Medical Devices Agency;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: Adverse drug events; Effectiveness; Exacerbations; Omalizumab; Severe asthma; ADRs; adverse drug reaction; AEs; adverse events; GETE; global evaluation of treatment effectiveness; GINA; Global Initiative for Asthma; HCRU; health care resource utilization;
Keywords: Cyclodextrin nanosponge; DPC; PMDA; Curcumin; Solubility enhancement; Nanocarrier;
Keywords: NSCLC; Non-Small Cell Lung Carcinoma; SCLC; Small Cell Lung Carcinoma; AC; Adenocarcinoma; LCT; Lung Carcinoid Tumor; LCC; Large Cell Carcinoma; CTC; Circulating Tumor Cells; UICC; The Union for International Cancer Control; CT; Computer-based Tomography;
Keywords: 4-ATP; 4-aminothiophenol; 4,4â²-DMAB; 4,4â²-dimercapto-azobenzene; 4-NTP; 4-nitrothiophenol; AAI; iron acetylacetonate; AF; acid fuchsine; AgTFA; (trifluoroacetylacetonoto) Ag(I); AO; acridine orange; CA; cellulose acetate; CMC; carboxymethyl cellulose;
Keywords: Skin sensitization testing; Alternative approaches; Non-animal methods; Regulatory requirements; Defined approaches; ANVISA; Brazilian Health Regulatory Agency; CCPSA; Canada Consumer Product Safety Act; CLP; Classification, Labelling, and Packaging; CONC
Keywords: Cerebrovascular complication; DOAC; direct thrombin inhibitor; factor Xa inhibitor; efficacy and safety; PMDA;
Keywords: Safety biomarkers; Regulatory qualification; Evidentiary standards; Drug development; FDA; US Food and Drug Administration; EMA; European Medicines Agency; PMDA; Pharmaceuticals and Medical Devices Agency of Japan; FNIH; Foundation for the National Instit
Keywords: Regenerative medicine; Guideline; FDA; PMDA; EMA; Harmonization;
Keywords: VTE; venous thromboembolism; ATE; arterial embolism and thrombosis; COCs; combined oral contraceptives; PMDA; Pharmaceuticals and Medical Devices Agency; LEP; low-dose estrogen progestin; MHLW; Ministry of Health, Labor and Welfare; EE; ethinylestradiol;
Keywords: DILI; drug-induced liver injury; ALT; alanine aminotransferase; ALP; alkaline phosphatase; BBW; black box warning; WDN; withdrawn; BC; bile canalicular; BSEP; bile salt export pump; MRP2; multidrug resistance-associated protein 2; SCHs; sandwich cultured
Keywords: VTE; (venous thromboembolism); ATE; (arterial embolism and thrombosis); COCs; (combined oral contraceptives); PMDA; (Pharmaceuticals and Medical Devices Agency); TFPI; (tissue factor pathway inhibitor); LEP; (low dose estrogen progestin); MHLW; (Ministry
Keywords: α-GST; alpha-glutathione S-transferase; B2M; beta-2 microglobulin; BUN; blood urea nitrogen; CROs; contract research organisations; Cr; creatinine; CysC; cystatin C; DIKI; drug-induced kidney-injury; EFPIA; European Federation of Pharmaceutical Industrie
Keywords: Copoly(ether-imide) membrane; Gas separation; BPDA; BKDA; PMDA; Carbon dioxide (CO2);
Keywords: ALT; alanine aminotransferase; AOPPs; advanced oxidation protein products; AST; aspartate aminotransferase; GGT; γ-glutamyl transferase; GPX; glutathione peroxidase; GSR; glutathione reductase; GST; glutathione S-transferase; HBSS; Hank's balanced salt
Regulatory-accepted drug development tools are needed to accelerate innovative CNS disease treatments
Keywords: ACR; American College of Radiology; AD; Alzheimer disease; ADNI; Alzheimer's Disease Neuroimaging Initiative; ALS; Amyotrophic Lateral Sclerosis; ASD; Autism Spectrum Disorder; BBB; Blood-Brain-Barrier; BEST; Biomarkers, Endpoints and other Tools; BLA; Bi
FDA, CE mark or something else?-Thinking fast and slow
Keywords: Device regulation; Substantial equivalence; MDA; PMDA; CE mark; EC type examination; Notified body; 510âK; PMA; STED; Harmonization of regulatory approvals;
A pragmatic method for transforming clinical research data from the research electronic data capture “REDCap” to Clinical Data Interchange Standards Consortium (CDISC) Study Data Tabulation Model (SDTM): Development and evaluation of REDCap2SDTM
Keywords: CDISC; Clinical Data Interchange Standards Consortium; SDTM; Study Data Tabulation Model; CDASH; Clinical Data Acquisition Standards Harmonization; EDC; electronic data capture; ODM; Operational Data Model; ADaM; Analysis Data Model; FDA; Food and Drug Ad
Deposition of PMDA-TFDB type polyimide onto microscale trenches patterned on silicon wafer using supercritical carbon dioxide
Keywords: Polyimide; Deposition; PMDA; TFDB; Supercritical carbon dioxide;
Novel co-polyimides containing pBAPS (bis [4-(4-aminophenoxy) phenyl] sulfone) for CO2 separation
Keywords: 6FDA; 4,4-hexafluoro isopropylidene diphthalicanhydride; BTDA; 3,34,4-benzophenone tetracarboxyclic dianhydride; pBAPS; bis [4-(4-aminophenoxy) phenyl] sulfone; mPDA; 1,3-phenylenediamine; DABA; 3,5-diamino benzoic acid; PMDA; pyromellitic dianhydride; TA
Condensation polymer/layered double hydroxide NCs: Preparation, characterization, and utilizations
Keywords: LDH; layered double hydroxide; NC; NCs; HA; hydroxyapatite; PMMA; poly methyl methacrylate; EVA; ethylene/vinyl acetate; SDBS; sodium dodecyl benzene sulfonate; PA; polyamides; PI; polyimide; PAI; poly(amide-imide); PMDA; pyromellitic dianhydride; TBAB; t
Segmental dynamics in hybrid polymer/POSS nanomaterials
Keywords: 6FDA; 2,2â²-bis(3,4-dicarboxyphenyl)-hexafluoropropane dianhydride; AFM; atomic force microscopy; BD; butanediol; BEMA; bisphenol A ethoxylate dimethacrylate; BPTA; benzophenonetetracarboxylic dianhydride; BSA; 4,4â²-(1,3-phenylenediisopropylidene) bisa
Progress in designing poly(amide imide)s (PAI) in terms of chemical structure, preparation methods and processability
Keywords: 4APS; 4-aminophenyl sulfone (4,4â²-diaminodiphenyl sulfone); AADs; amic acid diamines; BAFPB; 1,4-bis(4-amino-2-trifluoromethylphenoxy)benzene; BTDA; 3,3â²,4,4â²-benzophenonetetracarboxylic dianhydride; DMAB; 4-dimethylaminobenzhydrazide; DMAc; N,N-dim
Electrospun polyimide nanofibers and their applications
Keywords: AAI; [CH3COCHC(O)CH3]3Fe; AAPTMI; 5(6)-amino-1-(4â²-aminophenyl)-1,3-trimethylindane; ACAT; N,Nâ²-bis(4â²-aminophenyl)-1,4-quinonenediimine; AIE; aggregation-induced emission; BDAF; 2,2-bis[4-(4-aminophenoxy)phenyl]hexafluoropropane; blend-PI; blend-po
Scratching the surface: Exploratory analysis of key opinion leaders on rate limiting factors in novel adjuvanted-vaccine development
Keywords: CARG; compound annual growth rate; EPhMRA; European Pharmaceutical Marketing Research Association for the Anatomical Classification of Pharmaceutical Products; FDA; Food and Drug Administration; GSK; Glaxo Smith Kline; HBV; Hepatitis B Virus; HPV; Human P
Crosslinking polyimides for membrane applications: A review
Keywords: [BMPyr][Tf2N]; 1-butyl-1-pyrrolidinium bis(trifluoromethylsulfonyl)imide; [MOct3N][Tf2N]; methyltrioctylammonium bistriflimide; 4-MPDA; 3,5,6-tetramethyl-1,4-diphenylenediamine; 6FDA; hexafluoroisopropylidene-diphtalic anhydride; BAPP; 2,2-bis[4- (4-amino
Electroluminescence and impedance analyses of organic light emitting diodes using anhydride materials as cathode interfacial layers
Keywords: Cathode interfacial layer; PMDA; TMA; OLED
Rheological characterisation of recycled poly(ethylene terephthalate) modified by reactive extrusion
Keywords: Recycled PET; Reactive extrusion; PMDA; Rheological properties
Variability in neuronal activity in primate cortex during working memory tasks
Keywords: spike trains; monkeys; memory networks; parietal cortex; prefrontal cortex; computational models; AF; average firing frequency; CM; cross-modal; CV; coefficient of variation; CVAF; coefficient of variation of the average firing frequency; CVAFcm; coeffici
Challenges and lessons learned since implementation of the safety pharmacology guidance ICH S7A
Keywords: CNS; central nervous system; FDA; food and drug administration; GLP; good laboratory practice; GMP; good manufacturing practice; ICH; international conference on harmonization; IND; investigational new drug; NDA; new drug application; PMDA; pharmaceutical